Company Encyclopedia
View More
name
Cellebrite DI
CLBT.US
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company’s DI suite of solutions allows users to access, collect, review, extract, decode, decrypt, analyze, share, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations.
2.733 T
CLBT.USMarket value -Rank by Market Cap -/-

Financial Score

14/12/2025 Update
B
Application SoftwareIndustry
Industry Ranking34/256
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE20.46%A
    • Profit Margin16.74%A
    • Gross Margin83.88%A
  • Growth ScoreA
    • Revenue YoY18.37%B
    • Net Profit YoY124.09%A
    • Total Assets YoY32.59%A
    • Net Assets YoY50.07%A
  • Cash ScoreB
    • Cash Flow Margin597.25%C
    • OCF YoY18.37%B
  • Operating ScoreB
    • Turnover0.62B
  • Debt ScoreC
    • Gearing Ratio46.34%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Cellebrite DI (NasdaqGS:CLBT): Reassessing Valuation After Well‑Received Earnings and Guardian Platform Growth

    Cellebrite DI's shares rose 20% after a positive earnings report and growth in its Guardian platform. Despite a negative year-to-date return, the 3-year shareholder return is over 300%. Analysts debate whether CLBT is undervalued at $24.71 or overvalued at $13.51. The company benefits from a subscription-based model but faces risks from US federal contract reliance and competition. Simply Wall St provides analysis but not financial advice.

    Simplywall·
    US
    CLBT
    -1.26%
    Simplywall·
    US
    CLBT
    -1.26%

    Cellebrite DI Ltd. (CLBT): A bull case theory

    A bullish thesis on Cellebrite DI Ltd. (CLBT) by KairosPraxis was shared on X.com. As of November 28th, CLBT's share price was $16.86 with a trailing P/E of 44.37. Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe.

    MSN·
    US
    CLBT
    -1.26%
    MSN·
    US
    CLBT
    -1.26%

    Crescent Park Management L.P. Cuts Position in Cellebrite DI Ltd. $CLBT

    Crescent Park Management L.P. reduced its stake in Cellebrite DI Ltd. by 16.6% in Q2, now holding 570,232 shares. Other institutional investors also adjusted their positions in CLBT. The stock opened at $17.14 with a market cap of $4.10 billion. Analysts have mixed ratings, with a consensus of 'Moderate Buy' and an average target price of $24.00.

    Market Beat·
    US
    CLBT
    -1.26%
    Market Beat·
    US
    CLBT
    -1.26%

    Cellebrite DI’s Strategic Growth and Financial Prospects: A Buy Rating Driven by Key Acquisitions and Leadership Confidence

    William Blair analyst Jonathan Ho maintains a Buy rating on Cellebrite DI (CLBT) stock, citing strategic growth potential and financial prospects. Key factors include the acquisition of Corellium, enhancing digital investigative capabilities, and several growth catalysts leading up to 2026. These include product upgrades, anticipated FedRAMP approval, and a potential U.S. federal contract renewal. The appointment of Tom Hogan as CEO further boosts confidence. Lake Street also maintains a Buy rating with a $23.00 price target.

    Tip Ranks·
    US
    CLBT
    -1.26%
    Tip Ranks·
    US
    CLBT
    -1.26%

    Cellebrite Closes Acquisition of Corellium

    Cellebrite has completed its acquisition of Corellium, integrating Corellium's advanced virtualization technology and talent. This acquisition enhances Cellebrite's mobile security research and digital investigation capabilities. Corellium securityholders may receive up to $30 million based on performance milestones. The acquisition is expected to expand Cellebrite's AI-powered solutions, though it won't materially impact financials for Q4 and full-year 2025.

    Reuters·
    US
    CLBT
    -1.26%
    Reuters·
    US
    CLBT
    -1.26%
    © 2025 Longbridge｜Disclaimer